HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Thorsten Hanke Hans-Hinrich Sievers Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mohamed, S. A. Articles by Sievers, H.-H. Search for Related Content PubMed PubMed Citation Articles by Mohamed, S. A. Articles by Sievers, H.-H. Related Collections Coronary disease Molecular biology Valve disease

J Thorac Cardiovasc Surg 2005;130:1531-1536
© 2005 The American Association for Thoracic Surgery

Surgery for Congenital Heart Disease

Ubiquitin fusion degradation 1–like gene dysregulation in bicuspid aortic valve

^a Department of Cardiac Surgery, University of Schleswig-Holstein Campus Luebeck, Luebeck, Germany
^b the Center for Human Genetics, University of Bremen, Bremen, Germany

Received for publication April 19, 2005; revisions received June 17, 2005; accepted for publication August 8, 2005.

^_* Address for reprints: Hans-H. Sievers, MD, Department of Cardiac Surgery, University of Schleswig-Holstein Campus Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany (Email: sievers{at}medinf.mu-luebeck.de).

OBJECTIVE: Bicuspid aortic valve, the most common congenital cardiac malformation, is caused by fusion of valve cushions at the onset of valvulogenesis. Although its exact pathogenesis is still unclear, a genetic basis is appearing more and more likely. Search for a potential candidate gene by reviewing semilunar valve morphogenesis led us to the ubiquitin fusion degradation 1–like gene (UFD1L), which is highly expressed in the cardiac outflow tract during embryogenesis.

METHODS: Aortic valves were collected during surgery from 39 patients with bicuspid aortic valve (mean age 56.8 ± 18.1 years) and from 38 patients with tricuspid aortic valve (mean age 61.7 ± 16.1 years). Fluorescence in situ hybridization was performed for detection of microdeletion, quantitative reverse transcriptase–polymerase chain reaction to measure gene expression, and Western blotting to analyze the amount of UFD1L gene product.

RESULTS: No microdeletion was found in either group in the critical region of chromosome 22 containing the UFD1L gene. UFD1L gene expression, however, was significantly reduced in bicuspid aortic valve samples (median 787-fold) relative to tricuspid aortic valve samples (median 10,887-fold, P = .001). The amount of UFD1L gene product was also significantly diminished in bicuspid aortic valve samples (3.9 ± 2.6 vs 8.4 ± 4.8 optical density units, P < .05).

CONCLUSION: Bicuspid aortic valve was associated with downregulation of UFD1L gene expression, supporting the hypothesis that bicuspid aortic valve is a genetic disorder, with the UFD1L gene as a potential candidate gene.

This article has been cited by other articles:

				H.-H. Sievers In vivo tissue engineering an autologous semilunar biovalve: Can we get what we want? J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 20 - 22. [Full Text] [PDF]

				J. Aboulhosn and J. S. Child Left Ventricular Outflow Obstruction: Subaortic Stenosis, Bicuspid Aortic Valve, Supravalvar Aortic Stenosis, and Coarctation of the Aorta Circulation, November 28, 2006; 114(22): 2412 - 2422. [Full Text] [PDF]